EUTM file information

018558072

PROTEUS


September 13, 2021

Trademark Summary

The trademark PROTEUS was filed by Pythia Labs, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 11, 2021, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on January 9, 2022 by Ion Beam Applications en abrégé IBA, société anonyme on Likelihood of confusion. the opponent was represented by IPSILON BENELUX SA, aussi traitant sous le nom Distinctive+Ipsilon and its proceedings were handled in French The second opposition filed on November 29, 2021 by NETZSCH-Gerätebau GmbH on Likelihood of confusion. the opponent was represented by WUESTHOFF & WUESTHOFF PATENTANWÄLTE UND RECHTSANWALT PARTG MBB and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).


Goods And Services

  • The mark was filed in class 9 with following description of goods:
    1. Downloadable software for research and development of pharmaceutical preparations, bimolecular therapeutics, and medicines
    2. Downloadable software for research and development of biomolecules
    3. Downloadable software for the design and discovery of pharmaceutical preparations, bimolecular therapeutics, and medicines
    4. Downloadable software for the design and discovery of biomolecules
    5. Downloadable software for data analysis, pattern discovery, contextual prediction, predictive analytics, and predictive modelling for use in research and development of biomolecules
    6. Downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of biomolecules
    7. Downloadable software in the fields of molecular biology for chemical and molecular analysis prediction, identification, development, and discovery of molecular structures, pharmaceuticals, and medicines.
  • The mark was filed in class 42 with following description of goods:
    1. Design and development of customized artificial intelligence database software for others
    2. Research and development of software in the nature of a software module suite for the design and discovery of biomolecules
    3. Scientific and pharmaceutical artificial intelligence research services for others namely, development of artificial intelligence used to identify molecules and compounds for drug discovery and chemical development
    4. Software as a service (SAAS) services featuring software for research and development of pharmaceutical preparations, bimolecular therapeutics, and medicines
    5. Software as a services (SAAS) services featuring software for research and development of biomolecules
    6. Software as a services (SAAS) services featuring software for the design and discovery of pharmaceutical preparations, bimolecular therapeutics, and medicines
    7. Software as a service (SAAS) services featuring software for the design and discovery of biomolecules
    8. Software as a service (SAAS) services featuring software for data analysis, pattern discovery, contextual prediction, predictive analytics, and predictive modelling for use in research and development of biomolecules
    9. Software as a service (SAAS) services featuring software for searching, tracking, exploration and analysis of data for use in the research and development of biomolecules
    10. Software as a service (SAAS) services featuring software in the fields of molecular biology for chemical and molecular analysis prediction, identification, development, and discovery of molecular structures, pharmaceuticals, and medicines.